ACR Appropriateness Criteria™
Clinical Condition: Multiple Brain Metastases
Variant 1: 70-year-old man with four newly diagnosed, surgically accessible supratentorial brain metastases on magnetic resonance imaging. Karnofsky Performance Status 50. Untreated T3 N2 adenocarcinoma of lung. Bone/liver metastases also present.
Treatment |
Appropriateness Rating |
Comments |
Whole Brain Radiotherapy |
3000/10 |
8 |
|
2000/5 |
7 |
|
3750/15 |
4 |
|
4000/20 |
2 |
|
5000/25 |
2 |
|
Radiosensitizer |
Radiosensitizer plus whole brain
radiotherapy
|
2 |
|
Stereotactic
Radiosurgery |
Stereotactic radiosurgery alone |
2 |
|
Stereotactic radiosurgery plus whole brain
radiotherapy
|
2 |
|
Surgery |
Excise dominant lesion(s) |
2 |
|
Excise all lesions |
2 |
|
Appropriateness Criteria Scale
1 2 3 4 5 6 7 8 9
1=Least appropriate 9=Most appropriate |
Variant 2: 50-year-old man, two newly diagnosed, surgically accessible, supratentorial brain metastases on magnetic resonance imaging. Karnofsky Performance Status 90. Primary completely resected (T2 N0 adenocarcinoma of lung). No other systemic metastases.
Treatment |
Appropriateness Rating |
Comments |
Whole Brain Radiotherapy |
3750/15 |
6 |
|
4000/20
|
5 |
|
3000/10 |
4 |
|
2000/5 |
2 |
|
5000/25 |
2 |
|
Radiosensitizer |
Radiosensitizer plus whole brain
radiotherapy
|
2 |
|
Stereotactic
Radiosurgery |
Stereotactic radiosurgery plus whole brain radiotherapy
|
8 |
|
Stereotactic radiosurgery alone |
6 |
|
Surgery |
Excise dominant lesion(s) |
5 |
If dominant lesion is large, is associated with
mass effect, and caused midline shift. |
Excise all lesions |
4 |
|
Appropriateness Criteria Scale
1 2 3 4 5 6 7 8 9
1=Least appropriate 9=Most appropriate |
Variant 3: 50-year-old man, with six newly diagnosed supratentorial brain metastases on magnetic resonance imaging (three surgically accessible, three inaccessible). Karnofsky Performance Status 90. Primary completely resected (T2 N0 adenocarcinoma of lung). No other systemic metastases present.
Treatment |
Appropriateness Rating |
Comments |
Whole Brain Radiotherapy |
3000/10 |
8 |
|
3750/15 |
7 |
|
4000/20 |
4 |
|
2000/5 |
2 |
|
5000/25 |
2 |
|
Radiosensitizer |
Radiosensitizer plus whole brain
radiotherapy |
2 |
|
Stereotactic Radiosurgery |
Stereotactic radiosurgery |
2 |
|
Stereotactic radiosurgery plus whole brain radiotherapy |
2 |
|
Surgery |
Excise dominant lesion(s) |
2 |
|
Excise all lesions |
2 |
|
Appropriateness Criteria Scale
1 2 3 4 5 6 7 8 9
1=Least appropriate 9=Most appropriate |
Variant 4: 47-year-old woman with two newly diagnosed, surgically accessible, supratentorial brain metastases on magnetic resonance imaging. Karnofsky Performance Status 80. Two years status-post right modified radical mastectomy and adjuvant chemotherapy for T2 N1 adenocarcinoma of breast. Newly diagnosed pulmonary nodules also present.
Treatment |
Appropriateness Rating |
Comments |
Whole Brain Radiotherapy |
3750/15 |
8 |
|
3000/10 |
7 |
|
4000/20 |
5 |
|
2000/5
|
2 |
|
5000/25 |
2 |
|
Radiosensitizer |
Radiosensitizer plus whole brain radiotherapy |
2 |
|
Stereotactic
Radiosurgery |
Stereotactic radiosurgery plus whole brain radiotherapy |
7 |
|
Stereotactic radiosurgery alone |
6 |
|
Surgery |
Excise dominant lesion(s) |
2 |
|
Excise all lesions |
2 |
|
Appropriateness Criteria Scale
1 2 3 4 5 6 7 8 9
1=Least appropriate 9=Most appropriate |
Variant 5: 35-year-old woman with two newly diagnosed, surgically accessible, supratentorial brain metastases on magnetic resonance imaging. Karnofsky Performance Status 100. Status-post wide local excision of Clark's level IV melanoma. No other metastases.
Treatment |
Appropriateness Rating |
Comments |
Whole Brain Radiotherapy |
3750/15 |
6 |
|
3000/10 |
5 |
|
4000/20 |
2 |
|
2000/5 |
2 |
|
5000/25 |
2 |
|
Radiosensitizer |
Radiosensitizer plus whole brain
radiotherapy
|
2 |
|
Stereotactic
Radiosurgery |
Stereotactic radiosurgery alone |
8 |
|
Stereotactic radiosurgery plus whole brain
radiotherapy
|
8 |
|
Surgery |
Excise all lesion(s) |
6 |
|
Excise dominant lesions |
2 |
|
Appropriateness Criteria Scale
1 2 3 4 5 6 7 8 9
1=Least appropriate 9=Most appropriate |
Summary (Summarized by the National Guideline Clearinghouse)
Whole brain radiotherapy is an effective palliative treatment for patients with multiple brain metastases. About half of these patients experience an improvement in their neurologic symptoms. However, the majority of these patients do not achieve local control and frequently succumb from progressive brain disease. The apparent benefits of surgery need verification in prospective, randomized phase III clinical trials. The benefits of stereotactic radiosurgery have been demonstrated in one randomized study. The Radiation Therapy Oncology Group has an ongoing comparison of whole brain radiotherapy with and without stereotactic radiosurgery in patients with one, two, or three brain metastases measuring <4 cm in maximum diameter. Effective radiation sensitizers are needed, because whole brain radiotherapy alone, even in doses of 50 to 54.4 Gy, has not been associated with an improved survival outcome.